This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  84R12080 LED-D
 
  By: King of Hemphill H.B. No. 2813
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to health benefit plan coverage for ovarian cancer
  screening.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  The heading to Chapter 1370, Insurance Code, is
  amended to read as follows:
  CHAPTER 1370. CERTAIN TESTS FOR DETECTION OF HUMAN PAPILLOMAVIRUS,
  OVARIAN CANCER, AND CERVICAL CANCER
         SECTION 2.  Sections 1370.003(a) and (b), Insurance Code,
  are amended to read as follows:
         (a)  A health benefit plan that provides coverage for
  diagnostic medical procedures must provide to each woman 18 years
  of age or older enrolled in the plan coverage for expenses for an
  annual medically recognized diagnostic examination for the early
  detection of ovarian cancer and cervical cancer.
         (b)  Coverage required under this section includes at a
  minimum:
               (1)  a CA 125 blood test; and
               (2)  a conventional Pap smear screening or a screening
  using liquid-based cytology methods, as approved by the United
  States Food and Drug Administration, alone or in combination with a
  test approved by the United States Food and Drug Administration for
  the detection of the human papillomavirus.
         SECTION 3.  The change in law made by this Act applies only
  to a health benefit plan that is delivered, issued for delivery, or
  renewed on or after the effective date of this Act. A plan that is
  delivered, issued for delivery, or renewed before the effective
  date of this Act is governed by the law as it existed immediately
  before the effective date of this Act, and that law is continued in
  effect for that purpose.
         SECTION 4.  This Act takes effect September 1, 2015.